Liens UNIL

FR EN

Unisciences

Vous êtes ici: UNIL > Unisciences

Recherche
- Recherche
- Afficher les données
  de à

Service de radio-oncologie

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil

971 publications

... | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | ...

2010

Concurrent or sequential adjuvant letrozole and radiotherapy after conservative surgery for early-stage breast cancer (CO-HO-RT): a phase 2 randomised trial.

Azria David, Belkacemi Yazid, Romieu Gilles, Gourgou Sophie, Gutowski Marian, Zaman Khalil, Moscardo Carmen Llacer, Lemanski Claire, Coelho Michael, Rosenstein Barry et al., 2010. Lancet Oncology, 11 (3) pp. 258-265.

[DOI][WoS][Pmid][serval:BIB_F0D3E362858F]

Early Stage Primary Bone Lymphoma: A Retrospective, Multicenter Rare Cancer Network Study

Cai L., Stauder M.C., Zhang Y.J., Poortmans P., Li Y.X., Constantinou N., Thariat J., Kadish S., Ozsahin M., Mirimanoff R.O., 2010. pp. S84 dans 52nd Annual Meeting of the American-Society-For-Radiation-Oncology, International Journal of Radiation Oncology Biology Physics. Peer-reviewed.

[WoS][serval:BIB_B7EDAF6A30D1]

Early-stage favorable Hodgkin's lymphoma: is chemotherapy alone sufficient?

Ozsahin Mahmut, Ozsahin Hulya, 2010. Journal of Clinical Oncology, 28 (32) pp. 668-669; author reply 670.

[DOI][WoS][Pmid][serval:BIB_D3EFF4F722BB]

External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study.

Bolla M., Van Tienhoven G., Warde P., Dubois J.B., Mirimanoff R.O., Storme G., Bernier J., Kuten A., Sternberg C., Billiet I. et al., 2010. Lancet Oncology, 11 (11) pp. 1066-1073. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_98954F106F85]

Extraovarian primary peritoneal carcinoma

Nay Fellay C., Fiche M., Delaloye J.F., Bauer J., 2010. pp. 279-292 dans Belkacemi Yazid, Mirimanoff René-Olivier, Ozsahin Mahmut (eds.) Management of Rare Adult Tumours chap. 2, Springer.

[DOI][serval:BIB_FC1C78EA5408]

Facteurs de radiosensibilité tardive des tissus sains [Factors of late radiosensitivity of normal tissues]

Azria D., Pointreau Y., Toledano A., Ozsahin M., 2010. Cancer Radiothérapie, 14 (4-5) pp. 250-254.

[DOI][WoS][Pmid][serval:BIB_1E09C4F55A72]

Glioblastoma Expressing Mgmt Contribution Of Patrin-2 In Radiotherapy with Temozolomide

Perillo-Adamer F., Buchegger F., Ruegg C., Mirimanoff O., 2010. p. 719 dans 14th Annual Meeting of the Scientific Association of Swiss Radiation Oncology (SASRO), Strahlentherapie und Onkologie. Peer-reviewed.

[WoS][serval:BIB_BF84D0FADA63]

Hyperuricaemia and gout: state of the art and future perspectives.

Dalbeth Nicola, So Alexander, 2010. Annals of the Rheumatic Diseases, 69 (10) pp. 1738-1743.

[DOI][WoS][Pmid][serval:BIB_E026D23B9343]

Mandibular Osteoradionecrosis in Squamous-Cell Carcinoma of the Oral Cavity and Oropharynx Incidence and Risk Factors

Betz M., Ozsahin M., Broome M., Bouferrache K., Jaques B., Monnier V., 2010. p. 721 dans 14th Annual Meeting of the Scientific-Association-of-Swiss-Radiation-Oncology (SASRO), Strahlentherapie und Onkologie. Peer-reviewed.

[WoS][serval:BIB_DA3DBBA5A0E1]

Outcome and prognostic factors in olfactory neuroblastoma: a rare cancer network study.

Ozsahin Mahmut, Gruber Guenther, Olszyk Olimpia, Karakoyun-Celik Omur, Pehlivan Berrin, Azria David, Roelandts Martine, Kaanders Johannes H. A. M., Cengiz Mustafa, Krengli Marco et al., 2010. International Journal of Radiation Oncology, Biology, Physics, 78 (4) pp. 992-997.

[DOI][WoS][Pmid][serval:BIB_A3C81E57C6AA]

Pediatric Craniospinal Axis Irradiation with Helical Tomotherapy Preliminary Results

Herrmann E., Beck-Popovic M., Von der Weid N., Sajadi A., Rilliet B., Lacombe C., Letenneur G., Pica A., 2010. p. 725 dans 14th Annual Meeting of the Scientific-Association-of-Swiss-Radiation-Oncology (SASRO), Strahlentherapie und Onkologie. Peer-reviewed.

[WoS][serval:BIB_FFBA4DB1B260]

Peripheral organ doses by Monte Carlo for conventional breast cancer treatment

Joosten Andreas, Levi Fabio, Baechler Sébastien, Mirimanoff René-Olivier, Bochud François, Moeckli Raphael, 2010. pp. 727-728 dans 14th Annual Meeting of the Scientific-Association-of-Swiss-Radiation-Oncology (SASRO), Strahlentherapie Und Onkologie. Peer-reviewed.

[WoS][serval:BIB_944A1012227C]

Positron Emission Tomography and Computer Tomography (PET/CT) in Prostate, Bladder, and Testicular Cancers.

Zouhair A., Ozsahin M., Schaffer M., Albrecht S., Camus F., Jichlinski P., Mirimanoff R.O., Delaloye A.B., Meuwly J.Y., Prior J.O., 2010. Current Medicinal Chemistry, 17 (23) pp. 2492-502.

[DOI][WoS][Pmid][serval:BIB_E1C19424CA0E]

Radiation therapy for the solitary plasmacytoma

Kocak Esenguel, Ballerini Giorgio, Zouhair Abderrahim, Ozsahin Mahmut, 2010. Turkish Journal of Hematology, 27 (2) pp. 57-61.

[DOI][WoS][serval:BIB_0EEF3E165E2C]

Radiotherapy suppresses angiogenesis in mice through TGF-betaRI/ALK5-dependent inhibition of endothelial cell sprouting.

Imaizumi N., Monnier Y., Hegi M., Mirimanoff R.O., Rüegg C., 2010. Plos One, 5 (6) pp. e11084.

[URN][DOI][WoS][Pmid][serval:BIB_96AD29C4AC01]

Strategies to promote translational research within the European Organisation for Research and Treatment of Cancer (EORTC) Head and Neck Cancer Group: a report from the Translational Research Subcommittee.

Psyrri A., Licitra L., Lacombe D., Schuuring E., Budach W., Ozsahin M., Knecht R., Vermorken J.B., Langendijk J.A., 2010. Annals of Oncology, 21 (10) pp. 1952-1960.

[URN][DOI][WoS][Pmid][serval:BIB_22BFE2C6FAC4]

The management of brain metastases

Mirimanoff R.O., 2010. pp. S15 dans 2nd European Lung Cancer Conference, Journal of Thoracic Oncology. Peer-reviewed.

[WoS][serval:BIB_058904E8D7F1]

Toxicity And Dose Constraints With Adjuvant Imrt For Endometrial Cancers

Hallenbarter M., Loessl K., Bouchaab H., Aebersold D.M., Pica A., 2010. p. 735 dans 14th Annual Meeting of the Scientific-Association-of-Swiss-Radiation-Oncology (SASRO), Strahlentherapie und Onkologie. Peer-reviewed.

[WoS][serval:BIB_20BE54A3F8A7]

Toxicity at three years with and without irradiation of the internal mammary and medial supraclavicular lymph node chain in stage I to III breast cancer (EORTC trial 22922/10925).

Matzinger O., Heimsoth I., Poortmans P., Collette L., Struikmans H., Van Den Bogaert W., Fourquet A., Bartelink H., Ataman F., Gulyban A. et al., 2010. Acta Oncologica, 49 (1) pp. 24-34.

[DOI][WoS][Pmid][serval:BIB_2F30861B4E28]

Treatment of brain metastases from non-small cell lung cancer with whole-brain radiotherapy (wbrt) in combination with gefitinib (gft) or temozolomide (tmz): a randomized multicenter phase ii trial of the swiss group of clinical cancer research (sakk #70/03)

Pesce G. A., Von Moos R., D'Addario G., Caspar C. B., Fischer N., Anchisi S., Kotrubczik N., Zouhair A., Mayer M., Stupp R., 2010. p. 7 dans 9th Meeting of European Association of NeuroOncology, Neuro-Oncology. Peer-reviewed.

[WoS][serval:BIB_F4D360B3B250]

Whole brain radiotherapy with a conformational external beam radiation boost for lung cancer patients with 1-3 brain metastasis: a multi institutional study.

Casanova Nathalie, Mazouni Zohra, Bieri Sabine, Combescure Christophe, Pica Alessia, Weber Damien C., 2010. Radiation Oncology, 5 p. 13.

[URN][DOI][WoS][Pmid][serval:BIB_7C3F723ADF8F]

2009

Dépistage du cancer de la prostate: actualité [Prostate cancer screening: an update]

Tawadros T., Doerfler A., Treuthardt C., Praz V., Levi F., Zouhair A., Berthold D., Bauer J., Iselin C., Jichlinski P., 2009/12/02. Revue medicale suisse, 5 (228) pp. 2438-2441. Peer-reviewed.

[Pmid][serval:BIB_11E9631D48D2]

Molecular analysis of anaplastic oligodendroglial tumors in a prospective randomized study: A report from EORTC study 26951.

Kouwenhoven MC Gorlia T, Kros JM, Ibdaih A, Brandes AA, Bromberg JE, Mokhtari K, van Duinen SG, Teepen JL, Wesseling P, Vandenbos F et al., 2009/12. Neuro-oncology, Dec. 11 2009 (6) pp. 737-746. Peer-reviewed.

[serval:BIB_97E5B04A6162]

Radiochirurgie des tumeurs cérébrales

Mirimanoff RO, Pica A., 2009/07. pp. 177-193 dans Radiothérapie oncologique : concepts, techniques et applications cliniques, John Libbey.

[serval:BIB_4FBBABD843C7]

A Monte Carlo-based procedure for independent monitor unit calculation in IMRT treatment plans.

Pisaturo O., Moeckli R., Mirimanoff R.O., Bochud F.O., 2009. Physics in Medicine and Biology, 54 (13) pp. 4299-4310. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_B973549F0199]

A phase 2 randomized trial of radiotherapy (RT) plus panitumumab compared to chemoradiotherapy in patients with unresected, locally advanced squamous cell carcinoma of the head and neck (SCCHN): interim pooled safety analysis

Giralt J., Trigo J.M., Nuyts S., Ozsahin M., Markowitz A.B., Daisne J., Skladowski K., Lonchay C., Holeckova P., Smitt M., 2009. p. 475 dans 15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology, EJC Supplements. Peer-reviewed.

[DOI][WoS][serval:BIB_8A180C98D700]

Acute toxicity of curative radiotherapy for intermediate risk localized prostate cancer in the EORTC trial 22991

Matzinger O., Duclos F., van den Bergh A., Carrie C., Kitsios P., Villa S., Poortmans P., Sundar S., Collette L., Bolla M., 2009. pp. 151-152 dans 15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology, EJC Supplements. Peer-reviewed.

[DOI][WoS][serval:BIB_F7F7E7466944]

Acute toxicity of curative radiotherapy for intermediate- and high-risk localised prostate cancer in the EORTC trial 22991.

Matzinger O., Duclos F., van den Bergh A., Carrie C., Villà S., Kitsios P., Poortmans P., Sundar S., van der Steen-Banasik E.M., Gulyban A. et al., 2009. European Journal of Cancer, 45 (16) pp. 2825-2834.

[DOI][WoS][Pmid][serval:BIB_D6B21F03E134]

Adenoid Cystic Carcinoma of the Breast: A Rare Cancer Network Study

Ozsahin E., Sozzi W. Jeanneret , Kallel A., Villette S., Belkacemi Y., Vautravers C., Nguyen T., Miller R., Li Y.X., Khanfir K., 2009. pp. 184-185 dans 51st Annual Meeting of the American-Society-for-Radiation-Oncology, International Journal of Radiation Oncology Biology Physics. Peer-reviewed.

[DOI][WoS][serval:BIB_8CB0D3AF30E3]

Association of urethral toxicity with dose exposure in combined high-dose-rate brachytherapy and intensity-modulated radiation therapy in intermediate- and high-risk prostate cancer.

Ghadjar P., Matzinger O., Isaak B., Behrensmeier F., Stroux A., Rentsch C.A., Thalmann G.N., Aebersold D.M., 2009. Radiotherapy and Oncology, 91 (2) pp. 237-242.

[DOI][WoS][Pmid][serval:BIB_F12FE227F910]

Concurrent or Sequential Adjuvant Hormonoradiotherapy after Conservative Surgery for Early-Stage Breast Cancer: Clinical Results of the CO-HO-RT Phase II Randomized Trial.

Azria D., Ozsahin M., Romieu G., Gourgou S., Gutowski M., Zaman K., Lemanski C., Llacer C., Rosenstein B., Belkacemi Y., 2009. p. 536 dans 32nd Annual San Antonio Breast Cancer Symposium, Cancer Research. Peer-reviewed.

[WoS][serval:BIB_9EA8A32C182E]

Contribution of PaTrin-2 in Radiotherapy with Temozolomide for the Treatment of Glioblastoma Expressing MGMT

Perillo-Adamer F., Buchegger F., Rueegg C., Mirimanoff R., 2009. pp. 557-558 dans 51st Annual Meeting of the American-Society-for-Radiation-Oncology, International Journal of Radiation Oncology Biology Physics. Peer-reviewed.

[DOI][WoS][serval:BIB_8A849E718CE2]

Current developments in the radiotherapy approach to elderly and frail patients with glioblastoma multiforme.

Roa Wilson, Xing James Z., Small Cormac, Kortmann Rolf, Miriamanoff Rene, Okunieff Paul, Shibamoto Yuta, Jeremic Branislav, 2009. Expert Review of Anticancer Therapy, 9 (11) pp. 1643-1650.

[DOI][WoS][Pmid][serval:BIB_8B3942B70639]

Decrease in hemoglobin levels following surgery influences the outcome in head and neck cancer patients treated with accelerated postoperative radiotherapy.

Pehlivan B., Zouhair A., Luthi F., Bron L., Pasche P., Dragusanu D., Azria D., Matzinger O., Mirimanoff R.O., Ozsahin M., 2009. Annals of Surgical Oncology, 16 (5) pp. 1331-1336.

[URN][DOI][WoS][Pmid][serval:BIB_9F24F250B93C]

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.

Stupp R., Hegi M.E., Mason W.P., van den Bent M.J., Taphoorn M.J., Janzer R.C., Ludwin S.K., Allgeier A., Fisher B., Belanger K. et al., 2009. The lancet Oncology, 10 (5) pp. 459-466. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_9F4B47E9A16E]

EORTC-ROG expert opinion: radiotherapy volume and treatment guidelines for neoadjuvant radiation of adenocarcinomas of the gastroesophageal junction and the stomach.

Matzinger O., Gerber E., Bernstein Z., Maingon P., Haustermans K., Bosset J.F., Gulyban A., Poortmans P., Collette L., Kuten A., 2009. Radiotherapy and Oncology, 92 (2) pp. 164-175.

[DOI][WoS][Pmid][serval:BIB_778320E51E34]

Feasibility and efficacy of accelerated weekly concomitant boost postoperative radiation therapy combined with concomitant chemotherapy in patients with locally advanced head and neck cancer.

Pehlivan B., Luthi F., Matzinger O., Betz M., Dragusanu D., Bulling S., Bron L., Pasche P., Seelentag W., Mirimanoff R.O. et al., 2009. Annals of Surgical Oncology, 16 (5) pp. 1337-1343.

[URN][DOI][WoS][Pmid][serval:BIB_CE90665A3DFA]

Helical tomotherapy (HT) for the treatment of anal canal cancer: preliminary clinical results, and dosimetric comparison between HT and intensity-modulated or 3D conformal radiotherapy

Ugurluer G., Ballerini G., Letenneur G., Lacombe C., Pissaturo O., Matzinger O., Montemurro M., Zouhair A., Mirimanoff R.O., Ozsahin M., 2009. p. 331 dans 15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology, EJC Supplements. Peer-reviewed.

[DOI][WoS][serval:BIB_3AF879B6FBD5]

Helical tomotherapy or intensity-modulated radiation therapy in the treatment of anal cancer: experience of Geneva and Lausanne

Ozsahin M., Casanova N., Pachoud M., Moeckli R., Dipasquale G., Nouet P., Rouzaud M., Allal A., Zouhair A., Zilli T., 2009. p. 329 dans 15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology, EJC Supplements. Peer-reviewed.

[DOI][WoS][serval:BIB_213B7D9C9613]

High rate of severe radiation dermatitis during radiation therapy with concurrent cetuximab in head and neck cancer: results of a survey in EORTC institutes.

Giro C., Berger B., Bölke E., Ciernik I.F., Duprez F., Locati L., Maillard S., Ozsahin M., Pfeffer R., Robertson A.G. et al., 2009. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 90 (2) pp. 166-71. Peer-reviewed.

[DOI][Pmid][serval:BIB_CC85108C4935]

Irradiation corporelle totale : présent et avenir [Total body irradiation: present and future]

Zilli T., Miralbell R., Ozsahin M., 2009. Cancer Radiothérapie, 13 (5) pp. 428-433.

[DOI][WoS][Pmid][serval:BIB_47B085C31ED5]

La surveillance active dans la prise en charge du cancer de la prostate précoce. [Active surveillance for early-stage prostate cancer]

Jichlinski P., Berthold D. R., Zouhair A., Griesser A. C., Meuwly J. Y., Prior J. O., Lhermitte B., Doerfler A., Treuthardt C., Praz V. et al., 2009. Revue médicale suisse, 5 (228) pp. 2442-4, 2446-7.

[Pmid][serval:BIB_66220A2D6BE9]

Low dose (2x2 Gy) radiotherapy in indolent lymphoma : 2661

Schick U., Rossier C., Weber D.C., Ketterer N., Miralbell R., Mirimanoff R.O., Ozsahin M., 2009. p. 479 dans 51st Annual Meeting of the American-Society-for-Radiation-Oncology, International Journal of Radiation Oncology Biology Physics. Peer-reviewed.

[serval:BIB_368C952E4CB7]

Management of transitional-cell carcinoma of the renal pelvis and ureter.

Ozsahin M., Ugurluer G., Zounair A., 2009. Swiss Medical Weekly, 139 (25-26) pp. 353-356. Peer-reviewed.

[URN][WoS][Pmid][serval:BIB_B83DB9728685]

Mitomycin C with continuous fluorouracil or with cisplatin in combination with radiotherapy for locally advanced anal cancer (European Organisation for Research and Treatment of Cancer phase II study 22011-40014).

Matzinger O., Roelofsen F., Mineur L., Koswig S., Van Der Steen-Banasik E.M., Van Houtte P., Haustermans K., Radosevic-Jelic L., Mueller R.P., Maingon P. et al., 2009. European Journal of Cancer, 45 (16) pp. 2782-2791.

[DOI][WoS][Pmid][serval:BIB_D6ABD88E9451]

Monte Carlo peripheral dosimetry for primary breast cancer radiotherapy to estimate risks of secondary radiation-induced cancers

Joosten Andreas, Levi Fabio, Baechler Sébastien, Mirimanoff René-Olivier, Bochud François O., Moeckli Raphael, 2009. pp. ODE-23, p. 186 dans Genes and Diseases, CHUV Research Day, January 29, 2009, Université de Lausanne, Faculté de biologie et de médecine.

[URN][serval:BIB_611559586FE9]

Neoadjuvant chemotherapy and radiotherapy followed by surgery in selected patients with stage IIIB non-small-cell lung cancer: a multicentre phase II trial.

Stupp R., Mayer M., Kann R., Weder W., Zouhair A., Betticher D.C., Roth A.D., Stahel R.A., Majno S.B., Peters S. et al., 2009. Lancet Oncology, 10 (8) pp. 785-793.

[DOI][WoS][Pmid][serval:BIB_CADC41C5F836]

Physical considerations on discrepancies in target volume delineation.

Moeckli Raphael, Jeanneret Sozzi Wendy, Mirimanoff Rene-Olivier, Ozsahin Mahmut, Zouhair Abderrahim, Valley Jean-Francois, Bochud Francois, 2009. Zeitschrift für Medizinische Physik, 19 (4) pp. 224-235. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_768C4DD3E807]

Quality assurance in the 22991 EORTC ROG trial in localized prostate cancer: dummy run and individual case review.

Matzinger O., Poortmans P., Giraud J.Y., Maingon P., Budiharto T., van den Bergh A.C., Davis J.B., Musat E., Ataman F., Huyskens D.P. et al., 2009. Radiotherapy and Oncology, 90 (3) pp. 285-290.

[DOI][WoS][Pmid][serval:BIB_02E708EBBA0C]

Radiochemotherapy in locally advanced squamous cell carcinomas of the head and neck.

Matzinger O., Zouhair A., Mirimanoff R.O., Ozsahin M., 2009. Clinical Oncology, 21 (7) pp. 525-531.

[DOI][WoS][Pmid][serval:BIB_A882E991129E]

Rare malignant tumors of larynx and hypopharynx

Ikonomidis Christos, Bron Luc, 2009. dans Belkacémi Yvan, Mirimanoff René Olivier, Ozsahin Mahmut (eds.) Management of Rare Adult Tumors, Springer.

[serval:BIB_F10791A7E438]

The results of surgery, with or without radiotherapy, for primary spinal myxopapillary ependymoma: a retrospective study from the rare cancer network.

Pica A., Miller R., Villà S., Kadish S.P., Anacak Y., Abusaris H., Ozyigit G., Baumert B.G., Zaucha R., Haller G. et al., 2009. International Journal of Radiation Oncology, Biology, Physics, 74 (4) pp. 1114-1120.

[DOI][WoS][Pmid][serval:BIB_5B9F48AC4D7B]

Three years of adjuvant androgen deprivation with goserelin in patients with locally advanced prostate cancer treated with radiotherapy: Results at 10 years of EORTC trial 22863

Bolla M., Collette L., Van Tienhoven G., Warde P., Dubois J.B., Mirimanoff R.O., Storme G.A., Bernier J., Kuten A., Pierart M., 2009. p. 408 dans 15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology, EJC Supplements. Peer-reviewed.

[DOI][WoS][serval:BIB_2C13CD37F8B3]

2008

Open low-field magnetic resonance imaging for target definition, dose calculations and set-up verification during three-dimensional CRT for glioblastoma multiforme.

Weber D.C., Wang H., Albrecht S., Ozsahin M., Tkachuk E., Rouzaud M., Nouet P., Dipasquale G., 2008/10. Clinical Oncology (Royal College of Radiologists (Great Britain)), 20 (2) pp. 157-167. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_FB0B7CB085F1]

Traitements systémiques du cancer colorectal métastatique [Systemic treatment of metastatic colorectal cancer]

Montemurro M., Achtari L., Röth A., Halkic N., Luthi F., Ozsahin M., Denys A., Bauer J., Demartines N., Leyvraz S., 2008/05/21. Revue medicale suisse, 4 (158) pp. 1254-1257. Peer-reviewed.

[Pmid][serval:BIB_FCC1F9756723]

Molecular targeted agents combined with chemo-radiation in the treatment of locally advanced cervix cancer.

Herrera F.G., Vidal L., Oza A., Milosevic M., Fyles A., 2008/05. Reviews on recent clinical trials, 3 (2) pp. 111-120. Peer-reviewed.

[URN][DOI][Pmid][serval:BIB_3152C51D1022]

Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN).

Goldberg H., Miller R.C., Abdah-Bortnyak R., Steiner M., Yildiz F., Meirovitz A., Villà S., Poortmans P.M., Azria D., Zidan J. et al., 2008/02. Gynecologic oncology, 108 (2) pp. 298-305. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_DDD6255445F4]

Cancers du sein : comment associer l'hormonothérapie et la radiothérapie en situation adjuvante [How to combine hormonotherapy and radiation treatment in adjuvant breast cancer?]

Azria D., Ozsahin M., Gligorov J., Zaman K., Llacer Moscardo C., Lemanski C., Jacot W., Belkacémi Y., 2008. Cancer Radiothérapie, 12 (1) pp. 37-41.

[DOI][WoS][Pmid][serval:BIB_50E09CB712B4]

Concurrent chemoradiotherapy for malignant glioma: dead end or highway?

Mirimanoff R.O., 2008. Onkologie, 31 (8-9) pp. 430-431. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_0404C99795BC]

Concurrent or sequential adjuvant hormonoradiotherapy after conservative surgery for early stage breast cancer : first results of the CO-HO-RT phase II randomized trial : poster 234

Azria D., Ozsahin M., Romieu G., Gourgou S., Lemanski C., Belkacemi Y., Zaman K., 2008. p. 117 dans EBCC-6, European Breast Cancer Conference, European Journal of Cancer. Supplement. Peer-reviewed.

[serval:BIB_AB70BA3CE1E6]

Concurrent or sequential adjuvant hormonoradiotherapy after conservative surgery for early stage breast cancer: First results of the CO-HO-RT phase II randomized trial

Azria D., Belkacemi Y., Romieu G., Gourgou-Bourgade S., Zaman K., Gutowski M., Rosenstein B.S., Llacer Moscardo C., Lemanski C., Ozsahin M., 2008. p. 556 dans 2008 ASCO Annual Meeting, Journal of Clinical Oncology. Peer-reviewed.

[serval:BIB_D4EC272A519A]

Concurrent trastuzumab with adjuvant radiotherapy in HER2-positive breast cancer patients: acute toxicity analyses from the French multicentric study

Belkacémi Y., Gligorov J., Ozsahin M., Marsiglia H., De Lafontan B., Laharie-Mineur H., Aimard L., Antoine E.C., Cutuli B., Namer M. et al., 2008. Annals of Oncology : Official Journal of the European Society For Medical Oncology, 19 (6) pp. 1110-1116.

[URN][DOI][WoS][Pmid][serval:BIB_1DF774408A24]

Helical tomotherapy in the treatment of anal canal cancer : preliminary results

Ozsahin M., Pachoud M., Moeckli R., Letenneur G., Lacombe C., Montemurro M., Betz M., Matzinger O., Mirimanoff R.O, Zouhair A., 2008. p. 15098 dans 2008 ASCO Annual Meeting, Journal of Clinical Oncology. Peer-reviewed.

[serval:BIB_3855B134CB32]

Isolated limb perfusion with tumor necrosis factor and melphalan for non-resectable soft tissue sarcomas: long-term results on efficacy and limb salvage in a selected group of patients

Cherix S., Speiser M., Matter M., Raffoul W., Liénard D., Theumann N., Mouhsine E., Mirimanoff R.O., Leyvraz S., Lejeune F.J. et al., 2008. Jounal of Surgical Oncology, 98 (3) pp. 148-155. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_B92A352E8422]

Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3.

Gorlia T., van den Bent M.J., Hegi M.E., Mirimanoff R.O., Weller M., Cairncross J.G., Eisenhauer E., Belanger K., Brandes A.A., Allgeier A. et al., 2008. The Lancet Oncology, 9 (1) pp. 29-38.

[DOI][WoS][Pmid][serval:BIB_C39BE9B93B1F]

Patterns of failure and outcome in patients with carcinoma of the anal margin.

Khanfir K., Ozsahin M., Bieri S., Cavuto C., Mirimanoff R.O., Zouhair A., 2008. Annals of Surgical Oncology, 15 (4) pp. 1092-1098. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_A74F3876154F]

Pelvic radiotherapy and chemotherapy with or without surgery in the management of metastatic rectal cancer

Zouhair A., Ozsahin M., Ychou M., Dubois J.B., Mirimanoff R.O., Azria D., 2008. p. 15030 dans 2008 ASCO Annual Meeting, Journal of Clinical Oncology. Peer-reviewed.

[serval:BIB_4B316D4597E5]

Phyllodes tumor of the breast.

Belkacémi Y., Bousquet G., Marsiglia H., Ray-Coquard I., Magné N., Malard Y., Lacroix M., Gutierrez C., Senkus E., Christie D. et al., 2008. International Journal of Radiation Oncology, Biology, Physics, 70 (2) pp. 492-500. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_11319121633A]

Pilot study of induction chemotherapy followed by concomitant chemotherapy and IMRT or tomotherapy for nasopharyngeal carcinoma

Matzinger O., Ozsahin M., Bron L., Luthi F., 2008. dans 7th International Conference on Head and Neck Cancer.

[serval:BIB_1AB75A082218]

Postoperative combined radiotherapy (RT) and chemotherapy (CT) in patients with resected gastric adenocarcinoma

Khanfir K., Zouhair A., Bieri S., Montemurro M., Anchisi S., Zenhäusern R., Cornu P., Pachoud M., Mirimanoff RO., Ozsahin M., 2008. dans 12th Annual Meeting of the Scientific Association of Swiss Radiation Oncology (SASRO).

[serval:BIB_7B4F09662C62]

Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer: a study based on the EORTC Trial 22881-10882 'boost versus no boost'.

Collette S., Collette L., Budiharto T., Horiot J.C., Poortmans P.M., Struikmans H., Van den Bogaert W., Fourquet A., Jager J.J., Hoogenraad W. et al., 2008. European Journal of Cancer, 44 (17) pp. 2587-2599.

[DOI][WoS][Pmid][serval:BIB_4F71E475D9F7]

Primary breast lymphoma: patient profile, outcome and prognostic factors. A multicentre Rare Cancer Network study.

Jeanneret-Sozzi W., Taghian A., Epelbaum R., Poortmans P., Zwahlen D., Amsler B., Villette S., Belkacémi Y., Nguyen T., Scalliet P. et al., 2008. BMC Cancer, 8 (86) p. 86. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_EA5F79A09435]

Profile of European radiotherapy departments contributing to the EORTC Radiation Oncology Group (ROG) in the 21st century.

Budiharto T., Musat E., Poortmans P., Hurkmans C., Monti A., Bar-Deroma R., Bernstein Z., Tienhoven G., Collette L., Duclos F. et al., 2008. Radiotherapy and Oncology, 88 (3) pp. 403-410.

[DOI][WoS][Pmid][serval:BIB_48FCF01B1F81]

Radiation-induced side effects with or without systemic therapies: Prime time for prediction of individual radiosensitivity

Azria David, Rosenstein Barry S., Ozsahin Mahmut, 2008. International Journal of Radiation Oncology Biology Physics, 71 (5) pp. 1293-1294.

[DOI][WoS][serval:BIB_D9A83DCB6A7C]

Review: aggressive fibromatosis and breast implant.

Khanfir K., Zouhair A., 2008. Clinical Advances in Hematology and Oncology, 6 (9) pp. 693-694. Peer-reviewed.

[Pmid][serval:BIB_E0165035E293]

Single nucleotide polymorphisms, apoptosis, and the development of severe late adverse effects after radiotherapy.

Azria D., Ozsahin M., Kramar A., Peters S., Atencio D.P., Crompton N.E., Mornex F., Pèlegrin A., Dubois J.B., Mirimanoff R.O. et al., 2008. Clinical Cancer Research, 14 (19) pp. 6284-6288. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_E894A2187610]

Small cell (neuroendocrine) carcinoma of the prostate: etiology, diagnosis, prognosis, and therapeutic implications--a retrospective study of 30 patients from the rare cancer network.

Stein M.E., Bernstein Z., Abacioglu U., Sengoz M., Miller R.C., Meirovitz A., Zouhair A., Freixa S.V., Poortmans P.H., Ash R. et al., 2008. American Journal of the Medical Sciences, 336 (6) pp. 478-488. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_59D8B6B3E851]

Séquelles radio-induites et tests prédictifs [Radiation-induced sequelae: toward an individual profile]

Azria D., Belkacemi Y., Lagrange J.L., Chapet O., Mornex F., Maingon P., Hennequin C., Rosenstein B., Ozsahin M., 2008. Cancer Radiothérapie, 12 (6-7) pp. 619-624. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_F5B122E111A6]

The role of COX-2 in rectal cancer treated with preoperative radiotherapy.

Bouzourene H., Yan P., Sandmeier D., Zouhair A., Matter M., Vuilleumier H., Coucke P., 2008. Virchows Archiv, 452 (5) pp. 499-505. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_FB1A4B25BDF0]

2007

Outcome and prognostic factors in breast sarcoma: A multicenter study from the rare cancer network

Bousquet G., Confavreux C., Magne N., de Lara C. T., Poortmans P., Senkus E., de Lafontan B., Bolla M., Largillier R., Lagneau E. et al., 2007/12. Radiotherapy and Oncology, 85 (3) pp. 355-61. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_D9E31BDA6C06]

Sequential or Concomitant Chemotherapy and 3D Conformal Radiation Therapy With Dose-Volume Histogram Assessment in Limited Disease Small Cell Lung Cancer

Matzinger O., Ozsahin M., Khanfir K., El Hfid M., Peters S., Pachoud M., Bieri S., Mirimanoff R.O., Zouhair A., 2007/11., 49th Annual Meeting of the American Society for Therapeutic Radiology and Oncology pp. S529 dans International Journal of Radiation Oncology*Biology*Physics.

[DOI][WoS][serval:BIB_9C25BBB4829E]

6546 POSTER Postoperative 3D conformal radiation therapy with dose-volume histogram assessment in non small-cell lung cancer

Zouhair A., Dragusanu D., Matzinger O., Pehlivan B., Khanfir K., Ris H.B., Stupp R., Moeckli R., Mirimanoff R.O., Ozsahin M., 2007/09., 14th European Cancer Conference (ECCO 14) p. 371 dans European Journal of Cancer Supplements.

[DOI][WoS][serval:BIB_7B6D8935231E]

La radiothérapie par faisceaux de protons: bases physiques, indications et expérience suisse [Proton beam therapy: clinical indications and summary of the Swiss experience].

Weber D.C., Mirimanoff R.O., Miralbell R., 2007/09. Bulletin du Cancer, 94 (9) pp. 807-815.

[DOI][WoS][Pmid][serval:BIB_5636B0F6D996]

In regard to Ishikawa et al.: Cyclooxygenase-2 impairs treatment effect of radiotherapy for cervical cancer by inhibition of radiation-induced apoptosis (Int J Radiat Oncol Biol Phys 2006;66:1347-1355).

Herrera F.G., Fyles A., Milosevic M., 2007/07/01. International journal of radiation oncology, biology, physics, 68 (3) pp. 959-60; author reply 960. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_1AAB747917C6]

Indications et résultats du traitement des neurinomes de l'acoustique par radiothérapie stéréotaxique avec LINAC: résultats préliminaires [Indications and results of stereotactic radiosurgery with LINAC for the treatment of acoustic neuromas: preliminary results]

Radu A., Pica A., Villemure J.G., Maire R., 2007/07. Annales d'Oto-Laryngologie et de Chirurgie Cervico Faciale, 124 (3) pp. 110-114.

[DOI][Pmid][serval:BIB_05B937AE251B]

Abstractband sum 12 DEGRO Kongress, 11 SASRO Jahrestagung, 23 OGRO Jahrestangung, 2006, 2007 [Abstracts from the 13th DEGRO Annual Meeting, the 11th SASRO Annual Meeting and the 23rd OGRO Annual Meeting, 2006 and 2007]

Dragusonu D, Ozsohin M, Ris HB, Khanfir K, Stupp R, Matzinger O, Moeckli R, Zouhair A, 2007/06. pp. 1-200 dans Strahlentherapie und Onkologie. Peer-reviewed.

[DOI][Pmid][serval:BIB_89737A716038]

Limited stage small cell lung cancer: Results of combined modality treatment.

Khanfir K, Ozsahin M, Elhfid M, Bieri S, Cavuto C, Stupp R, Do HP, Mirimanoff RO, Zouhair A, 2007/06., 11th Annual Meeting of the Scientific Association of Swiss Radiation Oncology (SASRO) March 15–17, 2007 pp. 169-186 dans Strahlentherapie und Onkologie. Peer-reviewed.

[serval:BIB_C2986D6954F9]

A prospective phase I-II trial of the cyclooxygenase-2 inhibitor celecoxib in patients with carcinoma of the cervix with biomarker assessment of the tumor microenvironment.

Herrera F.G., Chan P., Doll C., Milosevic M., Oza A., Syed A., Pintilie M., Levin W., Manchul L., Fyles A., 2007/01/01. International journal of radiation oncology, biology, physics, 67 (1) pp. 97-103. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_E083DCF672DB]

Conservative management in patients with carcinoma of the anal margin

Khanfir K., Ozsahin M., Bieri S., Moeckli R., Mirimanoff R.O., Zouhair A., 2007. pp. S298 dans 49th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, International Journal of Radiation Oncology Biology Physics. Peer-reviewed.

[DOI][WoS][serval:BIB_76027DCE6D1B]

Improvement of saliva production in ENT cancer patients treated by IMRT

Bouferrache K., Moller R., Ozsahin E.M., Moeckli R., Madrid C., 2007. p. 56 dans Abstracts of the First World Congress of the International Academy of Oral Oncology (IAOO), Oral Oncology Supplement. Peer-reviewed.

[DOI][WoS][serval:BIB_5E3648B82A35]

Location, number and clinical significance of nutrient foramina in human long bones.

Kizilkanat E., Boyan N., Ozsahin E.T., Soames R., Oguz O., 2007. Annals of Anatomy = Anatomischer Anzeiger : Official Organ of the Anatomische Gesellschaft, 189 (1) pp. 87-95. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_C8CDE63EF1A8]

Postoperative 3D conformal radiation therapy with dose-volume histogram assessment in non small-cell lung cancer

Zouhair A., Drausanu D., Matzinger O., Pehlivan B., Khanfir K., Ris H.B., Stupp R., Moeckli R., Mirimanoff R.O., Ozsahin M., 2007. pp. S498-S499 dans 49th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, International Journal of Radiation Oncology Biology Physics. Peer-reviewed.

[DOI][WoS][serval:BIB_C9A972CD5FE4]

Postoperative 3D conformal radiation therapy with dose-volume histogram assessment in non small-cell lung cancer

Zouhair A., Dragusanu D., Matzinger O., Pehlivan B., Khanfir K., Ris H.B., Stupp R., Moeckli R., Mirimanoff R.O., Ozsahin M., 2007. p. 371 dans ECCO 14, Annual Meeting of the European Cancer Organisation, European Journal of Cancer. Supplement. Peer-reviewed.

[DOI][WoS][serval:BIB_67B9DD114F2E]

Postoperative 3D conformal RT (PORT) in non small cell lung cancer (NSCLC)

Dragusonu D., Ozsahin M., Ris H. B., Khanfir K., Stupp R., Matzinger O., Moeckli R., Mirimanoff R.O., Zouhair A., 2007. p. 173 dans 11th Annual Meeting of the Scientific Association of Swiss Radiation Oncology (SASRO), Strahlentherapie und Onkologie. Peer-reviewed.

[WoS][serval:BIB_600E08A9B93A]

Radiochimiothérapie dans les cancers ORL (EGFR+) [Radio-chemotherapy in head and neck cancer (EGFR+)].

Ozsahin M., Matzinger O., Zimmermann M., Zouhair A., 2007. Bulletin du Cancer, 94 (9) pp. 828-832.

[WoS][Pmid][serval:BIB_204AB02D8A2B]

The prognostic value of health-related quality-of-life data in predicting survival in glioblastoma cancer patients: results from an international randomised phase III EORTC Brain Tumour and Radiation Oncology Groups, and NCIC Clinical Trials Group study.

Mauer M., Stupp R., Taphoorn M.J., Coens C., Osoba D., Marosi C., Wong R., de Witte O., Cairncross J.G., Efficace F. et al., 2007. British journal of cancer, 97 (3) pp. 302-7. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_4236966F46FD]

Un guide pratique au traitement des gliomes [A practical guide for the management of gliomas]

Stupp R., Pica A., Mirimanoff R.O., Michielin O., 2007. Bulletin du cancer, 94 (9) pp. 817-22.

[DOI][WoS][Pmid][serval:BIB_CB9BE167BD46]

2006

Facteurs pronostiques et prise en charge des tumeurs rares. [Prognostic factors and management of rare cancers]

Belkacemi Y., Zouhair A., Ozsahin M., Azria D., Mirimanoff R. O., 2006/11. Cancer RadioThérapie, 10 (6-7) pp. 323-9.

[DOI][Pmid][serval:BIB_95E447402BBB]

Treatment results of 165 pediatric patients with non-metastatic nasopharyngeal carcinoma: a Rare Cancer Network study

Ozyar E., Selek U., Laskar S., Uzel O., Anacak Y., Ben-Arush M., Polychronopoulou S., Akman F., Wolden S. L., Sarihan S. et al., 2006/10. Radiotherapy and Oncology, 81 (1) pp. 39-46. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_9E5EEFA888F0]

Outcome and prognostic factors in cerebellar glioblastoma multiforme in adults: a retrospective study from the Rare Cancer Network

Weber D. C., Miller R. C., Villa S., Hanssens P., Baumert B. G., Castadot P., Varlet P., Abacioglu U., Igdem S., Szutowicz E. et al., 2006/09. International Journal of Radiation Oncology, Biology, Physics, 66 (1) pp. 179-86. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_0648AC389011]

Boost radiotherapy in young women with ductal carcinoma in situ: a multicentre, retrospective study of the Rare Cancer Network

Omlin A., Amichetti M., Azria D., Cole B. F., Fourneret P., Poortmans P., Naehrig D., Miller R. C., Krengli M., Gutierrez Miguelez C. et al., 2006/08. Lancet Oncology, 7 (8) pp. 652-6. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_2BFB3FDC59F8]

Genetic predictors of adverse radiotherapy effects: the Gene-PARE project

Ho A. Y., Atencio D. P., Peters S., Stock R. G., Formenti S. C., Cesaretti J. A., Green S., Haffty B., Drumea K., Leitzin L. et al., 2006/07. International Journal of Radiation Oncology, Biology, Physics, 65 (3) pp. 646-55. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_F8E9BF0EFFA7]

Primary spinal epidural lymphoma: patients' profile, outcome, and prognostic factors: a multicenter Rare Cancer Network study

Monnard V., Sun A., Epelbaum R., Poortmans P., Miller R. C., Verschueren T., Scandolaro L., Villa S., Majno S. B., Ostermann S. et al., 2006/07. International Journal of Radiation Oncology, Biology, Physics, 65 (3) pp. 817-23. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_275F5C3153A0]

Radiotherapy in the treatment of mucosal melanoma of the upper aerodigestive tract: analysis of 74 cases. A Rare Cancer Network study

Krengli M., Masini L., Kaanders J. H., Maingon P., Oei S. B., Zouhair A., Ozyar E., Roelandts M., Amichetti M., Bosset M. et al., 2006/07. International Journal of Radiation Oncology, Biology, Physics, 65 (3) pp. 751-9.

[DOI][WoS][Pmid][serval:BIB_134E33F3442A]

Adverse event reporting and developments in radiation biology after normal tissue injury: International Atomic Energy Agency consultation

Chen Y., Trotti A., Coleman C. N., Machtay M., Mirimanoff R. O., Hay J., O'Brien P C., El-Gueddari B., Salvajoli J. V., Jeremic B., 2006/04. International Journal of Radiation Oncology, Biology, Physics, 64 (5) pp. 1442-51.

[DOI][WoS][Pmid][serval:BIB_3B8ED11CCF3B]

Pineal parenchymal tumors of intermediate differentiation in adults: case report and literature review.

Pusztaszeri M., Pica A., Janzer R., 2006/04. Neuropathology, 26 (2) pp. 153-157. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_D7B474C45266]

Changing paradigms--an update on the multidisciplinary management of malignant glioma.

Stupp R., Hegi M.E., van den Bent M.J., Mason W.P., Weller M., Mirimanoff R.O., Cairncross J.G., and , 2006. Oncologist, 11 (2) pp. 165-180. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_4326A5ACFECB]

Conditions de travail reglementees pour les medecins suisses en formation: une annee d'experience. [Working conditions regulated by in-training Swiss physicians: one year of experience]

Matzinger O., 2006. Revue Médicale Suisse, 2 (83) pp. 2365-8.

[Pmid][serval:BIB_AAF1752E2180]

CPT-11 and concomitant hyperfractionated accelerated radiotherapy induce efficient local control in rectal cancer patients: results from a phase II.

Voelter V., Zouhair A., Vuilleumier H., Matter M., Bouzourene H., Leyvraz S., Bauer J., Coucke P., Stupp R., 2006. British journal of cancer, 95 (6) pp. 710-6. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_B1D318829039]

Feasibility and efficacy of subcutaneous amifostine therapy in patients with head and neck cancer treated with curative accelerated concomitant-boost radiation therapy.

Ozsahin M., Betz M., Matzinger O., Bron L., Luthi F., Pasche P., Azria D., Mirimanoff R.O., Zouhair A., 2006. Archives of Otolaryngology--Head and Neck Surgery, 132 (2) pp. 141-145. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_168851EBA7C3]

Listeria brain abscess, Pneumocystis pneumonia and Kaposi's sarcoma after temozolomide.

Ganière V., Christen G., Bally F., Guillou L., Pica A., de Ribaupierre S., Stupp R., 2006. Nature Clinical Practice. Oncology, 3 (6) pp. 339-343; quiz following 343. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_B9A6ED2EDBC0]

New trends in the medical management of glioblastoma multiforme: the role of temozolomide chemotherapy.

Dehdashti A.R., Hegi M.E., Regli L., Pica A., Stupp R., 2006. Neurosurgical Focus, 20 (4) pp. E6.

[Pmid][serval:BIB_D1A610DE5323]

Outcomes and patterns of failure in solitary plasmacytoma: a multicenter Rare Cancer Network study of 258 patients

Ozsahin M., Tsang R. W., Poortmans P., Belkacemi Y., Bolla M., Dincbas F. O., Landmann C., Castelain B., Buijsen J., Curschmann J. et al., 2006/01. International Journal of Radiation Oncology, Biology, Physics, 64 (1) pp. 210-7.

[DOI][WoS][Pmid][serval:BIB_3A10AEB3C6E9]

Preoperative hyper-fractionated accelerated radiotherapy (HART) in locally advanced rectal cancer (LARC) immediately followed by surgery. A prospective phase II trial.

Coucke P.A., Notter M., Stamm B., Matter M., Fasolini F., Schlumpf R., Matzinger O., Bouzourene H., On Behalf Of All Surgeons From Public Hospitals And Private Clinics, 2006. Radiotherapy and Oncology, 79 (1) pp. 52-58. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_F2112232A87B]

Prognostic factors in solitary plasmacytoma of the bone: a multicenter Rare Cancer Network study.

Knobel D., Zouhair A., Tsang R.W., Poortmans P., Belkacémi Y., Bolla M., Oner F.D., Landmann C., Castelain B., Ozsahin M., 2006. BMC Cancer, 6 p. 118. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_2D5473DF94BF]

Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial.

Mirimanoff R.O., Gorlia T., Mason W., Van den Bent M.J., Kortmann R.D., Fisher B., Reni M., Brandes A.A., Curschmann J., Villa S. et al., 2006. Journal of Clinical Oncology, 24 (16) pp. 2563-2569.

[DOI][WoS][Pmid][serval:BIB_EC0385B28C14]

The epidermal growth factor receptor (EGFR) in head and neck cancer: its role and treatment implications.

Zimmermann M., Zouhair A., Azria D., Ozsahin M., 2006. Radiation Oncology, 1 p. 11.

[DOI][WoS][Pmid][serval:BIB_510E90C30673]

The evolution of chemoradiation for glioblastoma: a modern success story

Mirimanoff R. O., 2006/01. Current Oncology Reports, 8 (1) pp. 50-3.

[Pmid][serval:BIB_379DED2944F0]

The reasons for discrepancies in target volume delineation : a SASRO study on head-and-neck and prostate cancers.

Jeanneret-Sozzi W., Moeckli R., Valley J.F., Zouhair A., Ozsahin E.M., Mirimanoff R.O., 2006. Strahlentherapie und Onkologie, 182 (8) pp. 450-457. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_0DD4945B41E1]

Treatment of penile carcinoma: to cut or not to cut?

Ozsahin M., Jichlinski P., Weber D.C., Azria D., Zimmermann M., Guillou L., Bulling S., Moeckli R., Mirimanoff R.O., Zouhair A., 2006. International Journal of Radiation Oncology, Biology, Physics, 66 (3) pp. 674-679. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_8FB576FEC915]

2005

Health-related quality of life in patients with glioblastoma: a randomised controlled trial

Taphoorn M. J., Stupp R., Coens C., Osoba D., Kortmann R., van den Bent M. J., Mason W., Mirimanoff R. O., Baumert B. G., Eisenhauer E. et al., 2005/12. Lancet Oncology, 6 (12) pp. 937-44.

[DOI][WoS][Pmid][serval:BIB_F8ABF8674D96]

Recidive biochimique apres traitement a visee curative d'un cancer localise de la prostate. [Biochemical failure after curative treatment for localized prostate cancer]

Zouhair A., Jichlinski P., Mirimanoff R. O., 2005/12. Revue Médicale Suisse, 1 (44) pp. 2844-6, 2848.

[Pmid][serval:BIB_29A37DECEA1A]

Protective role of melatonin in pinealectomized rat brains: in vivo magnetic resonance spectroscopic analysis

Hascalik S., Celik O., Karakas H. M., Parlakpinar H., Firat A. K., Ozsahin M., 2005/11. Journal of Pineal Research, 39 (4) pp. 342-5. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_FBDB58782C21]

Radiation recall: a well recognized but neglected phenomenon

Azria D., Magne N., Zouhair A., Castadot P., Culine S., Ychou M., Stupp R., Van Houtte P., Dubois J. B., Ozsahin M., 2005/11. Cancer Treatment Reviews, 31 (7) pp. 555-70.

[DOI][WoS][Pmid][serval:BIB_7379F66B3A9E]

Stature estimation based on hand length and foot length

Sanli S. G., Kizilkanat E. D., Boyan N., Ozsahin E. T., Bozkir M. G., Soames R., Erol H., Oguz O., 2005/11. Clinical Anatomy, 18 (8) pp. 589-96.

[DOI][WoS][Pmid][serval:BIB_7FBC4A27D14E]

CD4 and CD8 T-lymphocyte apoptosis can predict radiation-induced late toxicity: a prospective study in 399 patients

Ozsahin M., Crompton N. E., Gourgou S., Kramar A., Li L., Shi Y., Sozzi W. J., Zouhair A., Mirimanoff R. O., Azria D., 2005/10. Clinical Cancer Research, 11 (20) pp. 7426-33.

[DOI][WoS][Pmid][serval:BIB_716962901C2A]

Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)

Bernier J., Cooper J. S., Pajak T. F., van Glabbeke M., Bourhis J., Forastiere A., Ozsahin E. M., Jacobs J. R., Jassem J., Ang K. K. et al., 2005/10. Head and Neck, 27 (10) pp. 843-50.

[DOI][WoS][Pmid][serval:BIB_5A071662DC7D]

Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial

van den Bent M. J., Afra D., de Witte O., Ben Hassel M., Schraub S., Hoang-Xuan K., Malmstrom P. O., Collette L., Pierart M., Mirimanoff R. et al., 2005/09. Lancet, 366 (9490) pp. 985-90.

[DOI][WoS][Pmid][serval:BIB_78213DAF0199]

The Geneva and Lausanne (French-speaking Switzerland) experience: in favor of the transsphenoidal approach when feasible

Rilliet B., Vernet O., Pica A., 2005/08. Child's Nervous System, 21 (8-9) pp. 725-8.

[DOI][WoS][Pmid][serval:BIB_8135E1B6D8AF]

Radiation therapy and tamoxifen: concurrent or sequential? It's no longer the question!

Azria D., Pelegrin A., Dubois J.B., Mirimanoff R.O., Ozsahin M., 2005/06. Journal of Clinical Oncology, 23 (18) pp. 4239-4241; author reply 4241-4242. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_E9922DB10A1E]

Anémie et cancers des voies aérodigestives supérieures [Anemia in head and neck cancers]

Azria D., Zouhair A., Serre A., Lemanski C., Schneider M., Ozsahin M., Dubois J.B., Lartigau E., 2005/05. Bulletin du Cancer, 92 (5) pp. 445-451.

[WoS][Pmid][serval:BIB_64D201CBE58B]

Apport du PET en oncologie. [PET contribution in oncology]

Zimmermann M., Luthi F., Zouhair A., Ketterer N., Prior J. O., Kamel M. E., Bischof-Delaloye A., 2005/05. Revue Médicale Suisse, 1 (20) pp. 1335-8, 1341-2.

[Pmid][serval:BIB_31D5B29718F1]

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Stupp R., Mason W. P., van den Bent M. J., Weller M., Fisher B., Taphoorn M. J., Belanger K., Brandes A. A., Marosi C., Bogdahn U. et al., 2005/03. New England Journal of Medicine, 352 (10) pp. 987-96.

[URN][DOI][WoS][Pmid][serval:BIB_DEA725BDEE44]

External radiotherapy and anaemia treatment: state of the art.

Ozsahin M., Azria D., Beer K., Mirimanoff R.O., Zouhair A., 2005/01/08. Swiss medical weekly, 135 (1-2) pp. 4-10. Peer-reviewed.

[URN][WoS][Pmid][serval:BIB_8BEEB0A26553]

Combined modality treatment with full-dose chemotherapy and concomitant boost radiotherapy for advanced head and neck carcinoma

Kutter J., Ozsahin M., Monnier P., Stupp R., 2005/01. European Archives of Oto-Rhino-Laryngology, 262 (1) pp. 1-7.

[URN][DOI][WoS][Pmid][serval:BIB_F1B109E7527F]

Comparison of neoadjuvant cisplatin-based chemotherapy versus radiochemotherapy followed by resection for stage III (N2) NSCLC.

Pezzetta E., Stupp R., Zouhair A., Guillou L., Taffé P., von Briel C., Krueger T., Ris H.B., 2005. European Journal of Cardio-thoracic Surgery, 27 (6) pp. 1092-1098. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_71E656A93CAC]

Corrigendum to “Comparison of neoadjuvant cisplatin-based chemotherapy versus radiochemotherapy followed by resection for stage III (N2) NSCLC” [Eur J Cardiothorac Surg 27 (2005) 1092–1098]☆☆

Pezzetta Edgardo, Stupp Roger, Zouhair Abderrahim, Guillou Louis, Taffé Patrick, von Briel Christian, Krueger Thorsten, Ris Hans-Beat, 2005..

[DOI][WoS][serval:BIB_99BB9D93C90B]

Do sensitive patients have sensitive tumors?

Ozsahin M., Zouhair A., Crompton N.E.A., Moeckli R., Li L., Mirimanoff R.O., Azria D., 2005. pp. 504S dans 2005 ASCO Annual Meeting of the American Society of Clinical Oncology, Journal of Clinical Oncology. Peer-reviewed.

[WoS][serval:BIB_5A6A2B5DF908]

First stereotactic treatment of retino-blastoma using a micro-multileaf collimator

Moeckli R., Bulling S., Munier F., Balmer A., Abouzeid A., Chollet-Rivier M., Do H.P., Mercay A., Mirimanoff R. O., Valley J.F. et al., 2005. p. 136 dans 9th Annual Meeting of the Scientific Association of Swiss Radiation Oncology (SASRO), Strahlentherapie und Onkologie. Peer-reviewed.

[WoS][serval:BIB_753EAF6B4475]

Intensity modulated radiation therapy (IMRT) versus intensity modulated stereotactic radiation therapy (IMSRT) for children with intraocular retinoblastoma

Pica A., Munier F., Balmer A., Do H.P., Bressan S., Bulling S., Mirimanoff R.O., Moeckli R., 2005. p. 144 dans 9th Annual Meeting of the Scientific Association of Swiss Radiation Oncology (SASRO), Strahlentherapie und Onkologie. Peer-reviewed.

[WoS][serval:BIB_E0D579F0BFF1]

L'annonce d'une mauvaise nouvelle en oncologie [Breaking bad news]

Voelter V., Mirimanoff R.O., Stiefel F., Rousselle I., Leyvraz S., 2005. Revue médicale suisse, 1 (20) pp. 1350, 1352-3.

[Pmid][serval:BIB_8204845CAE88]

Letrozole sensitizes breast cancer cells to ionizing radiation

Azria D., Larbouret C., Cunat S., Ozsahin M., Gourgou S., Martineau P., Evans D. B., Romieu G., Pujol P., Pelegrin A., 2005. Breast Cancer Research, 7 (1) pp. R156-63. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_A4CAE8B80263]

Manifeste "politique de sante: halte au sabordage!": pour (presque) conclure. [Manifesto on "Health politics: stop the scuttling!": to (almost) conclude]

Frei A., de Vevey P., Kiefer B., Giorgis B., Jaquet J. L., Pilet F., Matzinger O., 2005. Revue Médicale Suisse, 1 (11) pp. 790-2.

[Pmid][serval:BIB_5C4A3E5CAE26]

MGMT gene silencing and benefit from temozolomide in glioblastoma.

Hegi M.E., Diserens A.C., Gorlia T., Hamou M.F., de Tribolet N., Weller M., Kros J.M., Hainfellner J.A., Mason W., Mariani L. et al., 2005. New England Journal of Medicine, 352 (10) pp. 997-1003.

[URN][DOI][WoS][Pmid][serval:BIB_59DF1F31757A]

Prognostic impact of epidermal growth factor receptor (EGFR) expression on loco-regional recurrence after preoperative radiotherapy in rectal cancer.

Azria D., Bibeau F., Barbier N., Zouhair A., Lemanski C., Rouanet P., Ychou M., Senesse P., Ozsahin M., Pèlegrin A. et al., 2005. BMC Cancer, 5 p. 62. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_F3CE985028E6]

Radiation-induced CD8 T-lymphocyte apoptosis predicts tumor sensitivity in head and neck cancer

Ozsahin M., Zouhair A., Crompton N.E.A., Moeckli R., Li L., Gourgou S., Mirimanoff R.O., Azria D., 2005. pp. 402-403 dans ECCO 13, 13rd European Conference on Clinical Oncology and Cancer Nursing, European Journal of Cancer. Supplement. Peer-reviewed.

[WoS][serval:BIB_587D75EF9FD0]

Traitement non chirurgical des rectites postactiniques ou radiques chroniques [Non-surgical treatment of acute and late radiation proctitis]

Zouhair A., Wiesel P.H., 2005. Revue médicale suisse, 1 (3) pp. 228, 230, 232-5.

[Pmid][serval:BIB_2D9385DE536A]

2004

Concomitant use of tamoxifen with radiotherapy enhances subcutaneous breast fibrosis in hypersensitive patients

Azria D., Gourgou S., Sozzi W. J., Zouhair A., Mirimanoff R. O., Kramar A., Lemanski C., Dubois J. B., Romieu G., Pelegrin A. et al., 2004/10. British Journal of Cancer, 91 (7) pp. 1251-60.

[DOI][WoS][Pmid][serval:BIB_78A35C7DC774]

La prévention des ossifications hétérotopiques après prothèse totale de la hanche. Mise au point [Prevention of heterotopic ossification following prosthetic total hip replacement]

Zouhair A., Ozsahin M., Garofalo R., Leyvraz P.F., Theumann N., Mirimanoff R.O., Coucke P.A., Mouhsine E., 2004/09. Revue medicale de la Suisse romande, 124 (9) pp. 579-582. Peer-reviewed.

[Pmid][serval:BIB_EF17DF310C1A]

Early improvements in vision after fractionated stereotactic radiotherapy for primary optic nerve sheath meningioma

Baumert B. G., Villa S., Studer G., Mirimanoff R. O., Davis J. B., Landau K., Ducrey N., Arruga J., Lambin P., Pica A., 2004/08. Radiotherapy and Oncology, 72 (2) pp. 169-74.

[DOI][WoS][Pmid][serval:BIB_09F022DD3BDB]

Late toxicity following conventional radiotherapy for prostate cancer: analysis of the EORTC trial 22863

Ataman F., Zurlo A., Artignan X., van Tienhoven G., Blank L. E., Warde P., Dubois J. B., Jeanneret W., Keuppens F., Bernier J. et al., 2004/07. European Journal of Cancer, 40 (11) pp. 1674-81.

[DOI][WoS][Pmid][serval:BIB_AE23332F9A30]

Quality assurance of the EORTC 26981/22981; NCIC CE3 intergroup trial on radiotherapy with or without temozolomide for newly-diagnosed glioblastoma multiforme: the individual case review

Ataman F., Poortmans P., Stupp R., Fisher B., Mirimanoff R. O., 2004/07. European Journal of Cancer, 40 (11) pp. 1724-30.

[DOI][WoS][Pmid][serval:BIB_C74C5C2B108D]

Hormonoradiotherapie adjuvante concomitante des cancers du sein: etat de l'art. [Adjuvant treatment of breast cancer by concomitant hormonotherapy and radiotherapy: state of the art]

Azria D., Lemanski C., Zouhair A., Gutowski M., Belkacemi Y., Dubois J. B., Romieu G., Ozsahin M., 2004/06. Cancer RadioThérapie, 8 (3) pp. 188-96.

[DOI][Pmid][serval:BIB_81E4BA634F5F]

New radiotherapy technologies for meningiomas: 3D conformal radiotherapy? Radiosurgery? Stereotactic radiotherapy? Intensity-modulated radiotherapy? Proton beam radiotherapy? Spot scanning proton radiation therapy. . . or nothing at all?

Mirimanoff R. O., 2004/06. Radiotherapy and Oncology, 71 (3) pp. 247-9.

[DOI][WoS][Pmid][serval:BIB_293DAAFABFE7]

Literature-based recommendations for treatment planning and execution in high-dose radiotherapy for lung cancer

Senan S., De Ruysscher D., Giraud P., Mirimanoff R., Budach V., 2004/05. Radiotherapy and Oncology, 71 (2) pp. 139-46.

[DOI][WoS][Pmid][serval:BIB_75B2BE755194]

Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer

Bernier J., Domenge C., Ozsahin M., Matuszewska K., Lefebvre J. L., Greiner R. H., Giralt J., Maingon P., Rolland F., Bolla M. et al., 2004/05. New England Journal of Medicine, 350 (19) pp. 1945-52. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_7D5E10EB0204]

Renal insufficiency in patients with hematologic malignancies undergoing total body irradiation and bone marrow transplantation: a prospective assessment

Miralbell R., Sancho G., Bieri S., Carrio I., Helg C., Brunet S., Martin P. Y., Sureda A., Gomez De Segura G., Chapuis B. et al., 2004/03. International Journal of Radiation Oncology, Biology, Physics, 58 (3) pp. 809-16. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_ECA2B3897A0A]

A prospective study of salivary gland function in patients undergoing radiotherapy for squamous cell carcinoma of the oropharynx

Moller P., Perrier M., Ozsahin M., Monnier P., 2004/02. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics, 97 (2) pp. 173-89. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_20D3450030B2]

Accelerated postoperative radiotherapy with weekly concomitant boost in patients with locally advanced head and neck cancer

Zouhair A., Azria D., Pasche P., Stupp R., Chevalier J., Betz M., Mirimanoff R. O., Ozsahin M., 2004/02. Radiotherapy and Oncology, 70 (2) pp. 183-8.

[DOI][WoS][Pmid][serval:BIB_7EE7B9C7AC71]

The origin of brain metastases in patients with an undiagnosed primary tumour

Agazzi S., Pampallona S., Pica A., Vernet O., Regli L., Porchet F., Villemure J. G., Leyvraz S., 2004/02. Acta Neurochirurgica, 146 (2) pp. 153-7.

[DOI][WoS][Pmid][serval:BIB_461DB65BB557]

A pilot study of silicone tissue expander prosthesis to protect the small bowell during radiation therapy for uterine malignancies

Zouhair A., Delaloye J. F., Ozsahin M., Azria D., Cuttat J. F., Levorato A., Do H. P., Coucke P. A., 2004. Turkish Journal of Cancer, 34 pp. 11-18.

[serval:BIB_41A8C96C3E2B]

Can we afford to add chemotherapy to radiotherapy for glioblastoma multiforme? Cost-identification analysis of concomitant and adjuvant treatment with temozolomide until patient death.

Wasserfallen J.B., Ostermann S., Pica A., Mirimanoff R.O., Leyvraz S., Villemure J.G., Stupp R., 2004. Cancer, 101 (9) pp. 2098-2105. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_752F8C3A497E]

Cancer du poumon : portrait 2003

Luthi F., Monnerat C., Zouhair A., Ris H. B., Stupp R., 2004. Médecine et Hygiène, 62 (2477) pp. 776-782.

[serval:BIB_332FCA022320]

Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy.

Huguenin P., Beer K.T., Allal A., Rufibach K., Friedli C., Davis J.B., Pestalozzi B., Schmid S., Thöni A., Ozsahin M. et al., 2004. Journal of Clinical Oncology, 22 (23) pp. 4665-4673. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_77349890A2A0]

Decreased local control following radiation therapy alone in early-stage glottic carcinoma with anterior commissure extension.

Zouhair A., Azria D., Coucke P., Matzinger O., Bron L., Moeckli R., Do H.P., Mirimanoff R.O., Ozsahin M., 2004. Strahlentherapie und Onkologie, 180 (2) pp. 84-90. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_2C6956794B20]

Fetal dose reduction in head and neck radiotherapy of a pregnant woman.

Moeckli R., Ozsahin M., Pache G., Valley J.F., Mirimanoff R.O., Azria D., 2004. Zeitschrift für medizinische Physik, 14 (3) pp. 168-72. Peer-reviewed.

[Pmid][serval:BIB_7D50C3B30C4B]

Imagerie des sarcomes.

Theumann N, Leyvraz PF, Garofalo R, Zouhair A, Mouhsine E, 2004. Revue Médicale de la Suisse Romande, 124 pp. 589-592.

[serval:BIB_31368]

Irinotecan-induced interstitial pneumonia.

Michielin O., Udry E., Périard D., Matzinger O., Lobrinus J.A., Stupp R., 2004. Lancet Oncology, 5 (5) pp. 322-324. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_FAADB151B2AE]

La gynécomastie sous anti-androgènes: un mal inéluctable? La radiothérapie: une solution simple et efficace! [Antiandrogen gynecomastia: an inescapable harm? Radiotherapy: a simple and efficient solution!]

Couke P.A., Jichliski P., Matzinger O., Ozsahin M., Bulling S.M., Zouhair A., 2004/01. Revue medicale de la Suisse romande, 124 (1) pp. 51-54. Peer-reviewed.

[Pmid][serval:BIB_2EFB598119D4]

Non-functioning pituitary carcinoma

Imboden P. N., Borruat F. X., De Tribolet N., Meagher-Villemure K., Pica A., Gomez F., 2004. Pituitary, 7 (3) pp. 149-56.

[DOI][Pmid][serval:BIB_3F4F0E039D02]

Optimisation in stereotactic radiosurgery of AVMs: II. Comparison of arc and MMLC therapy.

Tercier P.A., Aroua A., Mirimanoff R.O., Valley J.F., 2004. Zeitschrift für medizinische Physik, 14 (4) pp. 222-229. Peer-reviewed.

[Pmid][serval:BIB_B11C0A33990E]

Potential role of stereotactic linac based radiotherapy using micromulti leaf collimator in the treatment of bilateral retinoblastomas

Pica A., Munier F., Balmer A., Do H.P., Pasche G., Wang H., Moeckli R., 2004. p. 103 dans 8th Annual Meeting of the Scientific Association of Swiss Radiation Oncology (SASRO), Strahlentherapie und Onkologie. Peer-reviewed.

[WoS][serval:BIB_ECE520851B5C]

Prévention des ossifications hétérotopiques après prothèse totale de hanche.

Zouhair A, Ozsahin M, Garofalo R, Leyvraz PF, Theumann N, Mirimanoff RO, Coucke PA, Moushine E, 2004. Revue Médicale de la Suisse Romande, 2004 pp. 579-82.

[serval:BIB_31411]

Systemic melanoma metastatic to the retina and vitreous.

Zografos L., Mirimanoff R.O., Angeletti C.A., Frosini R., Beati D., Schalenbourg A., Chamot L., 2004. Ophthalmologica, 218 (6) pp. 424-433.

[DOI][WoS][Pmid][serval:BIB_46E172AFEAB3]

The use of epoetin in radio-oncology : controversial results of a well-intended study. .

Ozsahin M, Beer K.T, 2004. Bulletin suisse du cancer pp. 212-216.

[serval:BIB_33147]

2003

Clinical outcome following combination of cutting balloon angioplasty and coronary beta-radiation for in-stent restenosis: a report from the RENO registry

Roguelov C., Eeckhout E., De Benedetti E., Coucke P., Silber S., Baumgart D., Albiero R., Bonan R., Wegscheider K., Urban P., 2003/12. pp. 706-9 dans Journal of Invasive Cardiology.

[Pmid][serval:BIB_1BB7DCFE1C53]

Induction treatment before surgery for non-small cell lung cancer

Eberhardt W. E., Albain K. S., Pass H., Putnam J. B., Gregor A., Assamura H., Mornex F., Senan S., Belderbos J., Westeel V. et al., 2003/12. Lung Cancer, 42 Suppl 1 pp. S9-14.

[DOI][WoS][Pmid][serval:BIB_CAB7595114B9]

Prognostic factors for low-grade gliomas

Stupp R., Janzer R. C., Hegi M. E., Villemure J. G., Mirimanoff R. O., 2003/12. Seminars in Oncology, 30 (6 Suppl 19) pp. 23-8.

[DOI][WoS][Pmid][serval:BIB_5614C7083329]

Radiotherapy in low-grade gliomas: Cons

Mirimanoff R. O., Stupp R., 2003/12. Seminars in Oncology, 30 (6 Suppl 19) pp. 34-8.

[DOI][WoS][Pmid][serval:BIB_DBCDE5CDE28B]

Radiotherapie des seminomes testiculaires: ce qui a change ces dix dernieres annees. [Radiotherapy of testicular seminoma: changes over the past 10 years]

Mirimanoff R. O., 2003/11. Cancer RadioThérapie, 7 Suppl 1 pp. 70s-77s.

[Pmid][serval:BIB_60E957678D63]

Management of primary anal canal adenocarcinoma: a large retrospective study from the Rare Cancer Network

Belkacemi Y., Berger C., Poortmans P., Piel G., Zouhair A., Meric J. B., Nguyen T. D., Krengli M., Behrensmeier F., Allal A. et al., 2003/08. International Journal of Radiation Oncology, Biology, Physics, 56 (5) pp. 1274-83.

[DOI][WoS][Pmid][serval:BIB_E355732939D4]

Outcome and prognostic factors in orbital lymphoma: a Rare Cancer Network study on 90 consecutive patients treated with radiotherapy.

Martinet S., Ozsahin M., Belkacémi Y., Landmann C., Poortmans P., Oehlere C., Scandolaro L., Krengli M., Maingon P., Miralbell R. et al., 2003/03/15. International journal of radiation oncology, biology, physics, 55 (4) pp. 892-898. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_D45A822ADB01]

Cancer de l'oesophage : quel standard de traitement pour quel patient?

Matter M., Ozsahin E.M., Gillet M., 2003. Médecine et Hygiène, 61 (2442) pp. 1297-1308.

[serval:BIB_00423D497C4F]

Cancer du bas rectum. Traitement pré-opératoire : que choisir ?

Coucke P., Azria D., Matzinger O., Zouhair A., 2003. Oncologie, 5 pp. 269-76.

[serval:BIB_A912B5BDCD54]

Fish oil prevents the adrenal activation elicited by mental stress in healthy men.

Delarue J., Matzinger O., Binnert C., Schneiter P., Chioléro R., Tappy L., 2003. Diabetes and Metabolism, 29 (3) pp. 289-295.

[DOI][WoS][Pmid][serval:BIB_487E05A184AF]

Impaired insulin response after oral but not intravenous glucose in heart- and liver-transplant recipients.

Henchoz E., D'Alessio D.A., Gillet M., Halkic N., Matzinger O., Goy J.J., Chioléro R., Tappy L., Schneiter P., 2003. Transplantation, 76 (6) pp. 923-929. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_CF71F5AB7D0E]

Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group.

Zucca E., Conconi A., Mughal T.I., Sarris A.H., Seymour J.F., Vitolo U., Klasa R., Ozsahin M., Mead G.M., Gianni M.A. et al., 2003. Journal of Clinical Oncology, 21 (1) pp. 20-27. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_F4E02920A4C2]

Preoperative hyperfractionated accelerated radiotherapy (HART) and concomitant CPT-11 in locally advanced rectal carcinoma: a phase I study.

Voelter V., Stupp R., Matter M., Gillet M., Bouzourene H., Leyvraz S., Coucke P., 2003. International journal of radiation oncology, biology, physics, 56 (5) pp. 1288-94. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_DAD8929B7EA3]

Radiotherapie des séminomes testiculaires : ce qui a changé ces 10 dernières années.

Mirimanoff R.O, 2003. Cancer Radiother., 7 pp. 70-77.

[serval:BIB_28196]

Radiothérapie externe accélérée postopératoire des carcinomes épidermoïdes localement évolués de la sphère ORL: étude prospective de phase II [Prospective study of accelerated postoperative radiation therapy in patients with squamous-cell carcinoma of the head and neck]

Zouhair A., Coucke P.A., Azria D., Pache P., Stupp R., Moeckli R., Mirimanoff R.O., Ozsahin M., 2003. Cancer Radiothérapie, 7 (4) pp. 231-236. Peer-reviewed.

[Pmid][serval:BIB_81AA14D0107B]

Shortened irradiation scheme, continuous infusion of 5-fluorouracil and fractionated mitomycin C in locally advanced anal carcinomas. Results of a phase II study of the European Organization for Research and Treatment of Cancer. Radiotherapy and Gastrointestinal Cooperative Groups.

Bosset J.F, Roelofsen F, Morgan D.A, Budach V, Coucke P, Jager J.J, Van Der Steen-Banasik E, Triviere N, Stuben G, Puyraveau M et al., 2003. Eur J Cancer, 39 (1) pp. 45-51.

[DOI][WoS][serval:BIB_28190]

2002

Early nutritional intervention in oropharyngeal cancer patients undergoing radiotherapy

Piquet M. A., Ozsahin M., Larpin I., Zouhair A., Coti P., Monney M., Monnier P., Mirimanoff R. O., Roulet M., 2002/09. Supportive Care in Cancer, 10 (6) pp. 502-4.

[DOI][WoS][Pmid][serval:BIB_55E64AE45F5B]

Acute toxicity of conventional radiation therapy for high-risk prostate cancer in EORTC trial 22863

Zurlo A., Collette L., van Tienhoven G., Blank L., Warde P., Dubois J., Jeanneret W., Storme G., Bernier J., Kuten A. et al., 2002/08. European Urology, 42 (2) pp. 125-32.

[DOI][WoS][Pmid][serval:BIB_359BA0A666F5]

Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial

Bolla M., Collette L., Blank L., Warde P., Dubois J. B., Mirimanoff R. O., Storme G., Bernier J., Kuten A., Sternberg C. et al., 2002/07. Lancet, 360 (9327) pp. 103-6.

[DOI][WoS][Pmid][serval:BIB_EA70FB692461]

Early nutritional intervention in oropharyngeal cancer patients undergoing radiotherapy.

Zouhair A, Piquet MA, Ozsahin M, Larpin I, Coti P, Monney M, Monnier Ph, Mirimanoff RO, Roulet M, 2002. Support Care Cancer, 10 pp. 502-504.

[serval:BIB_24189]

Effects of fatty acids on exercise plus insulin-induced glucose utilization in trained and sedentary subjects.

Matzinger O., Schneiter P., Tappy L., 2002. American Journal of Physiology. Endocrinology and Metabolism, 282 (1) pp. E125-E131. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_F08526D4D7B6]

Importance of the tumor regression assessment in predicting the outcome of locally advanced rectal cancer treated with preoperative radiotherapy.

Bouzourene H, Bosman FT, Seelentag W, Matter M, Coucke PA, 2002. Cancer, 94(4) pp. 1121-1130.

[serval:BIB_24115]

La radiothérapie externe post-opératoire dans les cancers pulmonaires non à petite cellule

Zouhair A., Ozsahin M., Coucke P. A., Mirimanoff R. O., 2002. Bulletin Suisse du Cancer, 22(4) pp. 182-185.

[serval:BIB_3D64DDC76536]

Outcome and patterns of failure in testicular lymphoma: a multicenter Rare Cancer Network study.

Zouhair A., Weber D., Belkacémi Y., Ketterer N., Dietrich P.Y., Villà S., Scandolaro L., Bieri S., Studer G., Delacretaz F. et al., 2002. International journal of radiation oncology, biology, physics, 52 (3) pp. 652-6. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_804FA61D8FBF]

Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide.

Stupp R., Dietrich P.Y., Ostermann Kraljevic S., Pica A., Maillard I., Maeder P., Meuli R., Janzer R., Pizzolato G., Miralbell R. et al., 2002. Journal of Clinical Oncology, 20 (5) pp. 1375-1382. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_1EAD5E1C02D8]

Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11

Contact
Annuaires

Informations légales
Plan du site
Edition